Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multicenter, Open Label, Randomized Comparative Trial of the Efficacy and Safety of a Single Bolus Recombinant Non-immunogenic Staphylokinase and Bolus-infusion of Alteplase in Patients With Massive Pulmonary Embolism (FORPE)

NCT04688320 is registered in ClinicalTrials.gov with Supergene, LLC as lead sponsor.

NCT NCT04688320
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04688320 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multicenter, Open Label, Randomized Comparative Trial of the Efficacy and Safety of a Single Bolus Recombinant Non-immunogenic Staphylokinase and Bolus-infusion of Alteplase in Patients With Massive Pulmonary Embolism (FORPE)
Lead sponsor
Supergene, LLC
Phase
Phase 3
Overall status
Completed
Start date
December 15, 2020
Completion date
July 27, 2023
Enrollment
310 (actual)
Sites
23

Conditions

As the registry lists them; a condition with its own page is linked.

massive pulmonary embolism